Literature DB >> 20487234

IIEF-15: unsuitable for assessing erectile function of young men?

Sybren Rynja1, Ruud Bosch, Esther Kok, Gerlof Wouters, Laetitia de Kort.   

Abstract

INTRODUCTION: The prevalence of erectile dysfunction (ED) is mainly studied in older males, whereas we measured prevalence of ED in young healthy males using a validated questionnaire. AIM: Assessing the prevalence of ED in young adult men using the International Index of Erectile Function (IIEF-15) and creating a benchmark for ED in this young age group for further research.
METHODS: Male students were randomly asked to participate. Men with history of sexual dysfunction or urologic disease were excluded. Age, having a relationship and the IIEF-15 were filled out anonymously and in private. Outcomes of all domains were separately analysed based on relationship and intercourse frequency. MAIN OUTCOME MEASURES: ED measured by the IIEF-15.
RESULTS: One hundred and fifty-one students, aged 21.8 years (17-35, SD 2.98) participated and 14 were excluded. Of 137 students, 81% reported to have an intimate relationship. ED appeared to be present in 46 students (33.6%). The answer "no sexual activity," resulting in a 0-score, was given inconsistently. Outcomes were analysed for students who gave this answer at least once compared with those who never did. Nobody had ED in the group "without 0-scores" (n = 91). All students in the group "with (inconsistent) 0-scores" (n = 46) had ED. Students with a relationship had ED in 24.3% compared with 73.1% in those without a relationship (P < 0.001).
CONCLUSION: When men with inconsistently answered IIEF-15 questionnaires are excluded, a 0% prevalence of ED is found in this age-group. The current scoring method however does not state that these questionnaires should be excluded, and results in a prevalence of ED of 34%. Possibly, the scoring method of the IIEF-15 needs to be reviewed when this questionnaire is used in young, healthy men in order to accurately measure the prevalence of ED.
© 2010 International Society for Sexual Medicine.

Entities:  

Mesh:

Year:  2010        PMID: 20487234     DOI: 10.1111/j.1743-6109.2010.01847.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  6 in total

1.  The relationship between resting heart rate variability and erectile tumescence among men with normal erectile function.

Authors:  Christopher B Harte
Journal:  J Sex Med       Date:  2013-06-26       Impact factor: 3.802

2.  Updating the International Index of Erectile Function: Evaluation of a Large Clinical Data Set.

Authors:  Andrew J Vickers; Amy L Tin; Karandeep Singh; Rodney L Dunn; John Mulhall
Journal:  J Sex Med       Date:  2019-12-05       Impact factor: 3.802

3.  Prevalence and risk factors for erectile dysfunction and lower urinary tract symptoms in Russian Federation men: analysis from a national population-based multicenter study.

Authors:  I A Korneyev; T A Alexeeva; S H Al-Shukri; A N Bernikov; A A Erkovich; A A Kamalov; M I Kogan; V N Pavlov; V N Zhuravlev; D Y Pushkar
Journal:  Int J Impot Res       Date:  2016-02-11       Impact factor: 2.896

4.  Association between body size and composition and erectile dysfunction in older men: Osteoporotic Fractures in Men Study.

Authors:  Pranav S Garimella; Misti L Paudel; Kristine E Ensrud; Lynn M Marshall; Brent C Taylor; Howard A Fink
Journal:  J Am Geriatr Soc       Date:  2013-01       Impact factor: 5.562

Review 5.  Sexual function outcomes following interventions for prostate cancer: are contemporary reports on functional outcomes misleading?

Authors:  Catherine E Lovegrove; Vincenzo Ficarra; Francesco Montorsi; James N'Dow; Andrea Salonia; Suks Minhas
Journal:  Int J Impot Res       Date:  2019-12-13       Impact factor: 2.896

Review 6.  A Psychosocial Approach to Erectile Dysfunction: Position Statements from the European Society of Sexual Medicine (ESSM).

Authors:  Marieke Dewitte; Carlo Bettocchi; Joanna Carvalho; Giovanni Corona; Ida Flink; Erika Limoncin; Patricia Pascoal; Yacov Reisman; Jacques Van Lankveld
Journal:  Sex Med       Date:  2021-10-07       Impact factor: 2.491

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.